{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:20:24Z","timestamp":1794738024305,"version":"4.9.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81627805"],"award-info":[{"award-number":["81627805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12026602"],"award-info":[{"award-number":["12026602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113783","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:03:57Z","timestamp":1745867037000},"page":"113783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Nanoparticle-mediated dual targeting of stromal and immune components to overcome fibrotic and immunosuppressive barriers in hepatocellular carcinoma"],"prefix":"10.1016","volume":"383","author":[{"given":"Xiangyi","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feichao","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113783_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13327","article-title":"Deciphering the tumour immune microenvironment of hepatocellular carcinoma","volume":"98","author":"Liu","year":"2023","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jgh.12091","article-title":"Tumor microenviroment and hepatocellular carcinoma metastasis","volume":"28","author":"Wang","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.24384","article-title":"Hepatic stellate cells: partners in crime for liver metastases?","volume":"54","author":"Kang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2025.113783_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/gutjnl-2018-317257","article-title":"Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma","volume":"69","author":"Liu","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.113783_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymthe.2022.09.012","article-title":"Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma","volume":"31","author":"Liu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.113783_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0749-z","article-title":"Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response","volume":"7","author":"Keenan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.113783_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38093-5","article-title":"Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis","volume":"14","author":"Puttock","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113783_bb0040","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41423-024-01228-9","article-title":"Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumors","volume":"21","author":"Zheng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2024.10.010","article-title":"Biomaterials to regulate tumor extracellular matrix in immunotherapy","volume":"376","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113783_bb0050","first-page":"1","article-title":"Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113783_bb0055","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/acsnano.0c00417","article-title":"Photothermal depletion of Cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma","volume":"14","author":"Nicolas-Boluda","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113783_bb0060","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1021\/acsnano.8b04066","article-title":"Cell membrane coated semiconducting polymer nanoparticles for enhanced multimodal Cancer Phototheranostics","volume":"12","author":"Li","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113783_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.113783_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301257","article-title":"Targeted reprogramming of vitamin B3 metabolism as a Nanotherapeutic strategy towards Chemoresistant cancers","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113783_bb0075","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1021\/acsnano.4c01499","article-title":"Breaking physical barrier of fibrotic breast Cancer for photodynamic immunotherapy by remodeling tumor extracellular matrix and reprogramming Cancer-associated fibroblasts","volume":"18","author":"Qiu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113783_bb0080","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/1078-0432.CCR-11-1389","article-title":"Molecular pathways: digoxin use and estrogen-sensitive cancers\u2014risks and possible therapeutic implications","volume":"18","author":"Biggar","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03486-6","article-title":"Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial","author":"Kurzeder","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113783_bb0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tips.2022.10.002","article-title":"Digoxin as an emerging therapy in noncardiac diseases","volume":"44","author":"Dashti","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2025.113783_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003807","article-title":"Cardiac glycosides exert anticancer effects by inducing immunogenic cell death","volume":"4","author":"Menger","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113783_bb0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113783_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215925","article-title":"TGF-\u03b2 signaling networks in the tumor microenvironment","volume":"550","author":"Chan","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.113783_bb0110","first-page":"503","article-title":"The regulation of TGF-\u03b2\/SMAD signaling by protein deubiquitination, protein","volume":"5","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.113783_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","article-title":"New insights into TGF-\u03b2-Smad signalling","volume":"29","author":"ten Dijke","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2025.113783_bb0120","doi-asserted-by":"crossref","first-page":"E1239","DOI":"10.1073\/pnas.1718197115","article-title":"Chemotherapy induces enrichment of CD47+\/CD73+\/PDL1+ immune evasive triple-negative breast cancer cells","volume":"115","author":"Samanta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.113783_bb0125","first-page":"1","article-title":"Inhibition of immunosuppressive tumors by polymer-assisted inductions of immunogenic cell death and multivalent PD-L1 crosslinking","volume":"30","author":"Li","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113783_bb0130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.semcancer.2020.12.001","article-title":"Pivotal role of PD-1\/PD-L1 immune checkpoints in immune escape and cancer progression: their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals","volume":"86","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0135","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","article-title":"PD-L1 (B7-H1) competes with the RNA exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or chemotherapy","volume":"74","author":"Tu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.113783_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114532","article-title":"Alterations of ceramide synthesis induce PD-L1 internalization and signaling to regulate tumor metastasis and immunotherapy response","volume":"43","author":"Wofford","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.113783_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110349","article-title":"PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-O receptor I versus II","volume":"38","author":"Sun","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.113783_bb0150","doi-asserted-by":"crossref","first-page":"14660","DOI":"10.1021\/acsami.9b03572","article-title":"Immobilized transforming growth factor-Beta 1 in a stiffness-tunable artificial extracellular matrix enhances Mechanotransduction in the epithelial mesenchymal transition of hepatocellular carcinoma","volume":"11","author":"Tang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113783_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-024-01887-0","article-title":"Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression","volume":"9","author":"Peng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113783_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000394","article-title":"Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma","volume":"8","author":"Ho","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.113783_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","article-title":"Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma","volume":"72","author":"Cheng","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202409898","article-title":"Unraveling the role of the tumor extracellular matrix to inform nanoparticle Design for Nanomedicine","volume":"12","author":"Cassani","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113783_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02948-w","article-title":"Cascade-catalysed nanocarrier degradation for regulating metabolism homeostasis and enhancing drug penetration on breast cancer","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0180","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.7b01026","article-title":"Designing liposomes to suppress extracellular matrix expression to enhance drug penetration and pancreatic tumor therapy","author":"Ji","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113783_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113783_bb0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113783_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113783_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/science.abp8964","article-title":"The extracellular matrix and the immune system: a mutually dependent relationship","volume":"379","author":"Sutherland","year":"2023","journal-title":"Science (80-.)"},{"key":"10.1016\/j.jconrel.2025.113783_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.3MR1116-468R","article-title":"Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche","volume":"102","author":"Asimakopoulos","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0210","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"Cogliati","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0215","first-page":"A51","article-title":"Single-cell landscape of cancer-associated fibroblasts in immunotherapy resistance of hepatocellular carcinoma","volume":"72","author":"Wong","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.113783_bb0220","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113783_bb0230","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113783_bb0235","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.113783_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-014-0476-9","article-title":"Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor \u03b2\/Smad signaling and associates with favorable breast cancer disease outcomes","volume":"16","author":"Guo","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0245","first-page":"1413","article-title":"Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta\/Smad signaling","volume":"63","author":"Baldwin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ptr.8352","article-title":"Epoxymicheliolide reduces radiation-induced senescence and extracellular matrix formation by disrupting NF-\u03baB and TGF-\u03b2\/SMAD pathways in lung Cancer","volume":"39","author":"Zhou","year":"2025","journal-title":"Phyther. Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0255","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.7b00784","article-title":"Spatiotemporal control of supramolecular self-assembly and function","author":"Zhan","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113783_bb0260","article-title":"Selective degradation of PD-L1 in Cancer cells by enzyme-instructed self-assembly","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113783_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202002780","article-title":"Combined tumor environment triggered self-assembling peptide nanofibers and inducible multivalent ligand display for Cancer cell targeting with enhanced sensitivity and specificity","volume":"16","author":"Chen","year":"2020","journal-title":"SMALL"},{"key":"10.1016\/j.jconrel.2025.113783_bb0270","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2020.03.030","article-title":"Undefined\/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis","volume":"73","author":"Sangiovanni","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1163-6","article-title":"Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP","volume":"38","author":"Sun","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0280","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.trecan.2024.03.003","article-title":"Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy","volume":"10","author":"Demuynck","year":"2024","journal-title":"Trend. Cancer"},{"key":"10.1016\/j.jconrel.2025.113783_bb0285","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008866","article-title":"Trial watch: immunogenic cell death inducers for anticancer chemotherapy","volume":"4","author":"Pol","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2025.113783_bb0290","doi-asserted-by":"crossref","first-page":"S1547","DOI":"10.1016\/S0016-5085(24)04005-8","article-title":"Regulation of CEACAM1 in metabolic dysfunction associated steatohepatitis (mash) and HCC by TGF-\u03b2 signaling","volume":"166","author":"Bhowmick","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.113783_bb0295","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-3388","article-title":"Targeting liver specific \u00dfII-Spectrin to prevent the development of metabolic dysfunction associated steatohepatitis (MASH) through CEACAM1 axis","volume":"84","author":"Bhowmick","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0300","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0305","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.113783_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.06.014","article-title":"Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor","volume":"42","author":"You","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113783_bb0315","article-title":"Dendritic cell mineralocorticoid receptor controls blood pressure by regulating T helper 17 differentiation: role of the Plc\u03b21\/4-Stat5-NF-\u03baB pathway","author":"Wang","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2025.113783_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202415078","article-title":"Plasma membrane targeted photodynamic Nanoagonist to potentiate immune checkpoint blockade therapy by initiating tumor cell Pyroptosis and depleting infiltrating B cells","volume":"37","author":"Zhong","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113783_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113606","article-title":"Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy","volume":"381","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113783_bb0330","doi-asserted-by":"crossref","first-page":"20820","DOI":"10.1021\/acsami.5c00029","article-title":"PD-L1-targeting autophagy modulator to upregulate MHC-I and activate photo-immunotherapy for metastatic tumor eradication","volume":"17","author":"Lu","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113783_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137303","article-title":"Silver niobate\/platinum piezoelectric heterojunction enhancing intra-tumoral infiltration of immune cells for transforming \u201ccold tumor\u201d into \u201chot tumor\u201d","volume":"690","author":"Zhang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2025.113783_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123104","article-title":"Remodeling tumor microenvironment by versatile nanoplatform orchestrated mechanotherapy with chemoimmunotherapy to synergistically enhance anticancer efficiency","volume":"317","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113783_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03315-9","article-title":"GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer","volume":"44","author":"Xie","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113783_bb0350","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/annonc\/mdw041","article-title":"Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies","volume":"27","author":"Sanmamed","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40207-y","article-title":"Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation","volume":"14","author":"Meng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113783_bb0360","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0365","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.trecan.2021.06.009","article-title":"Tumour microenvironment 3D-modelling: simplicity to complexity and back again","volume":"7","author":"Carter","year":"2021","journal-title":"Trend. Cancer"},{"key":"10.1016\/j.jconrel.2025.113783_bb0370","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2020.07.017","article-title":"Intrahepatic cholangiocarcinoma: a single-cell resolution unraveling the complexity of the tumor microenvironment","volume":"73","author":"Fabris","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2023.2677","article-title":"Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma a review","volume":"10","author":"Cappuyns","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2025.113783_bb0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/14737140.2022.2041415","article-title":"Patient stratification in hepatocellular carcinoma: impact on choice of therapy","volume":"22","author":"Papaconstantinou","year":"2022","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.jconrel.2025.113783_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.113783_bb0390","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.7150\/thno.71873","article-title":"Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113783_bb0395","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:08:35Z","timestamp":1778674115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925004031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":79,"alternative-id":["S0168365925004031"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113783","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-mediated dual targeting of stromal and immune components to overcome fibrotic and immunosuppressive barriers in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113783"}}